An optimized workflow for MS-based quantitative proteomics of challenging clinical bronchoalveolar lavage fluid (BALF) samples

Abstract

Background Clinical bronchoalveolar lavage fluid (BALF) samples are rich in biomolecules, including proteins, and useful for molecular studies of lung health and disease. However, mass spectrometry (MS)-based proteomic analysis of BALF is challenged by the dynamic range of protein abundance, and potential for interfering contaminants. A robust, MS-based proteomics compatible sample preparation workflow for BALF samples, including those of small and large volume, would be useful for many researchers. Results We have developed a workflow that combines high abundance protein depletion, protein trapping, clean-up, and in-situ tryptic digestion, that is compatible with either qualitative or quantitative MS-based proteomic analysis. The workflow includes a value-added collection of endogenous peptides for peptidomic analysis of BALF samples, if desired, as well as amenability to offline semi-preparative or microscale fractionation of complex peptide mixtures prior to LC–MS/MS analysis, for increased depth of analysis. We demonstrate the effectiveness of this workflow on BALF samples collected from COPD patients, including for smaller sample volumes of 1–5 mL that are commonly available from the clinic. We also demonstrate the repeatability of the workflow as an indicator of its utility for quantitative proteomic studies. Conclusions Overall, our described workflow consistently provided high quality proteins and tryptic peptides for MS analysis. It should enable researchers to apply MS-based proteomics to a wide-variety of studies focused on BALF clinical specimens.

A proteomics-based survey reveals thrombospondin-4 as a ligand regulated by the mannose receptor in the injured lung

“…BALF samples are well suited for analysis by mass spectrometry (MS)-based proteomics ( 23 ). Therefore, we performed a proteomic analysis of BALF samples from LPS-treated mice to identify ligands subject to MR-dependent uptake under these conditions.…”

Novel Approach to Exploring Protease Activity and Targets in HIV-associated Obstructive Lung Disease using Combined Proteomic-Peptidomic Analysis

“…The BALF was processed as previously described. [ 17 ] Briefly, the cell-free BALF samples were centrifuged twice to separate out the insoluble component of BALF from the soluble fraction. Endogenously produced peptides were collected from the soluble component of the supernatant via a 3kDa MW cutoff filter.…”

The MBO2/FAP58 heterodimer stabilizes assembly of inner arm dynein b and reveals axoneme asymmetries involved in ciliary waveform

“…Samples were digested and labeled with TMT reagents, dried down, and then fractionated offline as described above. Approximately ∼300–600 nanograms of each fraction was analyzed by capillary LC–MS with a Dionex UltiMate 3000 RSLC nano system on-line with an Orbitrap Eclipse mass spectrometer (Thermo Fisher Scientific) with FAIMS (high-field asymmetric waveform ion mobility) separation as described by Weise et al. , 2023 with minor modifications.…”

“…The Chlamydomonas reinhardtii protein sequence database was downloaded from https://phytozome-next.jgi.doe.gov/info/Creinhardtii_v5.6 and merged with two additional sequences, DRC1 and FAP58, plus a common lab contaminant protein database ( www.thegpm.org/cRAP/index.html ) (16,631 total protein sequences). The database search parameters were as previously described ( Weise et al. , 2023 ) with the exception that the fragment ion tolerance was 0.08 Da.…”

“…Peptides and proteins were identified using a 1% FDR and the Percolator algorithm ( Käll et al. , 2008 ) in Proteome Discover and quantified as described in Weise et al. , 2023 , with the exception that normalization was performed using alpha and beta tubulin.…”